Radicava Ors Kit
Product Images NDC 70510-2322

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Radicava Ors (NDC 70510-2322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shionogi Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure

Chemical structure depicting a heterocyclic compound with a five-membered ring containing two nitrogen atoms, a ketone group, a methyl substituent, and a phenyl group. This structural formula is associated with the active ingredient in RADICAVA by Shionogi Inc.*

FDA Label Image

Figure 01

A bar graph comparing the percentage of patients showing change in ALSFRS-R scores at Week 24 for RADICAVA versus placebo. The x-axis shows ranges of change scores from -21 to +2, with negative indicating worse and positive better outcomes. The y-axis indicates percent of patients. Black bars represent RADICAVA, and white bars represent placebo across the score intervals.*

FDA Label Image

Ifu Figure A

An instructional diagram showing components for dosing RADICAVA, including a bottle with a bottle cap, an oral syringe labeled with plunger, barrel, and syringe tip, and a bottle adapter with a ribbed end. The syringe features volume markings from 1 mL to 6 mL.*

FDA Label Image

Ifu Figure B

An instructional illustration showing a hand gripping a small bottle with a ribbed cap. Two vertical arrows beside the bottle indicate an up and down shaking motion. The image likely demonstrates how to properly shake the bottle before use for the product RADICAVA by Shionogi Inc.*

FDA Label Image

Ifu Figure C

An instructional illustration showing hands holding a vial with a detached cap beside it. An arrow indicates pressing down at the top of the vial, suggesting activation or opening. The drawing is black and white with shading to highlight the vial and hand position. The product is identified as RADICAVA by Shionogi Inc.*

FDA Label Image

Ifu Figure D

An instructional illustration showing a hand holding a syringe with volume markings, indicating the syringe plunger being pulled back (arrow pointing upward). The image likely demonstrates how to fill or draw fluid into the syringe. No specific product markings are visible beyond the illustration itself.*

FDA Label Image

Ifu Figure E

An instructional illustration showing a hand inserting a syringe into a bottle to withdraw liquid. The syringe is marked with volume measurements from 1 mL to 5 mL. An arrow indicates the downward motion of the syringe into the bottle.*

FDA Label Image

Ifu Figure F

An instructional illustration depicting two hands using a syringe to draw liquid from an opened bottle. The syringe is graduated for measurement, and an arrow indicates the downward direction of syringe insertion into the bottle. The image is associated with RADICAVA by Shionogi Inc.*

FDA Label Image

Ifu Figure G

An instructional illustration showing two hands preparing a syringe by attaching or filling it from a bottle held upside down. The syringe has volume markings visible, and an arrow indicates downward movement of the bottle onto the syringe.*

FDA Label Image

Ifu Figure H

An instructional illustration showing a hand drawing liquid from a bottle into a syringe. The syringe is marked with volume measurements in milliliters and is partially filled with liquid. The image depicts the process of withdrawing medication using a syringe and vial.*

FDA Label Image

Ifu Figure I

Illustration showing a syringe with volume markings from 1 mL to 5 mL, highlighting the 5 mL mark with a zoomed-in inset and an arrow labeled '5 mL'. This diagram indicates a measurement detail relevant to the RADICAVA product by Shionogi Inc.*

FDA Label Image

Ifu Figure J

An instructional illustration showing a person being administered an oral medication using a syringe without a needle, positioned at the mouth for oral dosing.*

FDA Label Image

Ifu Figure K

Instructional illustration showing a hand holding a bottle and turning the cap clockwise to open or close it. The bottle has a blank label and the turning motion is indicated by arrows and the text 'Turn clockwise.' This image is associated with RADICAVA by Shionogi Inc.*

FDA Label Image

Ifu Figure L

An instructional illustration showing a faucet with water droplets falling and two syringes positioned below it. One syringe is empty while the other syringe is marked with volume measurements up to 5 mL, suggesting cleaning or rinsing instructions related to liquid measurement or preparation.*

FDA Label Image

Ifu Figure N

An instructional illustration showing hands using a syringe to draw or administer liquid into a medical device or container. The syringe barrel is marked with volume measurements from 1 to 5 mL, and the hands are positioned to demonstrate proper handling technique.*

FDA Label Image

Ifu Figure O

An instructional illustration showing two hands assembling a syringe. The syringe is partially filled with a liquid labeled as water, with volume markings visible on the barrel up to 60 mL. The image likely demonstrates preparation steps for use.*

FDA Label Image

Ifu Figure P

An instructional diagram illustrating how to open a RADICAVA medication bottle. It shows a hand turning the cap clockwise, with arrows indicating the direction to turn the cap.*

FDA Label Image

Ifu Figure Q

An instructional illustration showing a water faucet dripping water and two syringes, one with volume markings from 1 to 5 mL and the other empty, arranged to suggest rinsing or cleaning. The image is black and white with simple line art.*

FDA Label Image

Ifui Figure M

An instructional illustration showing hands manipulating a syringe and a stopcock valve. The syringe is labeled with volume increments up to 60 mL and contains a liquid marked as water at about the 10 mL level. The illustration appears to demonstrate how to control or measure liquid flow using the stopcock valve on the attached tubing.*

FDA Label Image

Radicava Carton Sawaii

Packaging label for Radicava (edaravone) injection, 30 mg/100 mL (0.3 mg/mL) for intravenous infusion. The label indicates each 100 mL bag contains 30 mg edaravone and specifies inactive ingredients. It shows a 100 mL x 2 bags package with storage and usage instructions. Labeler is Shionogi Inc., manufactured by Sawai Pharmaceutical Japan, and marketed by Mitsubishi Tanabe Pharma America.*

FDA Label Image

Radicava Carton Terumo

Packaging label for RADICAVA (edaravone) Injection, showing 100 mL bags for intravenous infusion. Each bag contains 30 mg edaravone in a 100 mL solution (0.3 mg/mL). The label includes dosing instructions, storage conditions, and cautionary statements. It is labeled as Rx only and manufactured by Mitsubishi Tanabe Pharma, licensed to Shionogi Inc. The label features instructional images for infusion and displays NDC 70510-2171-2 with packaging of 2 bags per box.*

FDA Label Image

Radicava Ors Label Maintenance

Label for Radicava ORS (edaravone) Oral Suspension, 105 mg/5 mL, 50 mL bottle. The label includes directions for oral administration to shake before use and discard unused portion 15 days after first opening. Manufactured for Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ. Storage instructions specify refrigeration between 2°C and 8°C and precautions to protect from light. The label includes a barcode, lot and expiration date placeholders, and a QR code in a Quiet Zone.*

FDA Label Image

Radicava Ors Label Starter

Radicava ORS (edaravone) Oral Suspension 105 mg/5 mL pharmaceutical label for oral administration. The 35 mL bottle label includes dosing instructions to shake vigorously before use, storage guidelines, and expiration and lot number spaces. Manufactured for Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ. NDC 70510-2321-1, Rx only, by Shionogi Inc.*

FDA Label Image

Radicava Ors Maintenance Carton

Packaging label for RADICAVA ORS (edaravone) Oral Suspension, 105 mg/5 mL, by Shionogi Inc. The flat layout shows multiple panels including the proprietary name, active ingredient, strength, dosage form, and volume of 50 mL. It includes NDC number 70510-2322-1, barcode, storage and use instructions, and patient information advisories. The label features a teal accent stripe and the Shionogi Inc logo.*

FDA Label Image

Radicava Ors Starter Carton Outer

Radicava ORS 105 mg/5 mL (edaravone) oral suspension starter kit packaging label. The carton features product and dosage strength prominently, with instructions for oral administration and storage details. It is indicated as a prescription product labeled by Shionogi Inc., including a barcode and space for prescription information. The packaging also mentions contents such as oral syringes and adapter, with a white and orange color scheme.*

FDA Label Image

Radicava Ors Starter Inner Carton

The image shows a carton label for RADICAVA ORS (edaravone) Oral Suspension, 105 mg/5 mL, a liquid suspension for oral administration. The label indicates the product is prescription-only with a 35 mL quantity. The label includes storage, use, and patient instructions, and it is labeled for Shionogi Inc. and Mitsubishi Tanabe Pharma America Inc. The design features an orange stripe and text on a white background.*

FDA Label Image

Radicava Soft Bag Sawai

Radicava (edaravone) Injection 30 mg/100 mL (0.3 mg/mL) intravenous infusion bag label. The label includes NDC 70510-2171-1, directions for use, dosage and storage information, active and inactive ingredients, and manufacturer details (Sawai Pharmaceutical Japan). Marketed and distributed by Mitsubishi Tanabe Pharma America, Inc. Warnings and instructions for use are also present.*

FDA Label Image

Radicava Soft Bag Terumo

Label for Radicava (edaravone) Injection by Shionogi Inc., an intravenous infusion solution. The label shows strength as 30 mg per 100 mL (0.3 mg/mL) in a bag format. It includes dosage and storage instructions, manufacturer Terumo Corporation, and distributor Mitsubishi Tanabe Pharma America, Inc. Additional details include barcodes, discard instructions, and handling cautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.